KDM2A and breast cancer: Our previous study also showed that breast cancer-secreted TNF-α and IL-6 can drive the transformation of mammary fibroblast cells into CAFs by upregulating the expression of KDM2A and subsequently upregulating the expression of PD-L1, providing an immunosuppressive TME for breast cancer progression [27].